The World Health Organization (WHO) warned on Tuesday that children who have experienced organ inflammation as a result of COVID-19 infection should receive steroid treatment in the hospital.
The UN health body amended its recommendations after originally describing Multisystem Inflammatory Syndrome in Children Associated With COVID-19, or MIS-C, in May.
MIS-C is a rare but dangerous illness in which COVID-19-positive children develop inflammation in many body organs. Children with this syndrome require specialist treatment and may require admission to an intensive care unit. MIS-C is a dangerous disorder, but it can be treated and children can recover with the correct medical treatment.
Although children have a low risk of having severe or life-threatening COVID-19, several underlying characteristics make them more vulnerable to major organ inflammation caused by the virus.
Obesity, chronic lung illness, including asthma, cardiovascular disease, and immunosuppression are among these conditions.
After examining data from three observational studies that combined the experiences of 885 individuals, the WHO released its recommendation.